fig3
Figure 3. Relationship between genetic variants of pharmacologically relevant members of the SLC family 28, substrate drugs affected by changes in these proteins, and cancers treated with these compounds. SLC: Solute carrier.
Figure 3. Relationship between genetic variants of pharmacologically relevant members of the SLC family 28, substrate drugs affected by changes in these proteins, and cancers treated with these compounds. SLC: Solute carrier.
All published articles will preserved here permanently:
https://www.portico.org/publishers/oae/